Llorenç Coll, PhD, CEO & CTO

Focused on the fields of cancer and genetics for the development and further market insights of Aniling’s technologies. Co-founder of Aniling and co-inventor of the first set of Aniling’s technologies.

Miguel A Peinado, PhD, CSO

Since 90’s contributing on cancer genomics and epigenomics with patents and publications in leading scientific journals. Co-founder of Aniling and co-inventor of the first set of Aniling’s technologies.

Jaume Amat, Strategic Advisor

Over 10 years of experience as a serial entrepreneur, consultant and advisor in the biotech sector. Co-founder of Archivel Farma and currently CEO at Rob Surgical Systems and Specipig.

Sheila Santin, PhD, Research Associate

Molecular Laboratory Unit. Extensive expertise in massive sequencing related projects. Previous positions at Genomics and Bioinformatics and Genotyping Units at IMPPC, CRG and Fundació Puigvert.

Núria Seguí, PhD, Research Associate

Molecular Laboratory Unit. Wide background in cancer genetics and usage of Next Generation Sequencing technologies focused on clinical purposes. Previous positions at University of Cambridge and ICO-Idibell.

Júlia Matas, PhD Candidate

Molecular Laboratory Unit. Graduated Pharmacist, specialized in Biomedicine. PhD Student in Epigenetic mechanisms of cancer and cell differentiation.

Ester Cuenca, PhD, Research Associate

Bioinformatics Unit. Deep knowledge of next generation sequencing procedures and bioinformatic analysis. Previous positions at Broad Institute of MIT and Harvard, Massachusetts General Hospital, Welcome Trust Sanger Institute, CRG and VHIR.

Pau Carrió, PhD, Research Associate

Bioinformatics Unit. Data scientist expert in the genomics field. Previous positions at Research Programme on Biomedical Informatics – GRIB – IMIM under eTOX project.